A quitting trial’s baseline table is not a test that randomization worked
Read who entered each group and the size of starting differences without treating a p-value as a balance certificate or an outcome.
No Vape · Updated

Check the table’s timing and population
Find whether the table describes everyone randomized or a later analysis subset. Then identify what baseline means for that trial. Starting characteristics and outcomes measured after intervention answer different questions, even when the same score appears in both places. Keep group sizes and the table legend visible instead of assuming every row uses the enrollment total.
CONSORT 2025 item 25 calls for baseline characteristics for each group and explains that proper random assignment does not ensure observed similarity. Its explanation advises against significance testing of baseline differences. We use this reporting guidance for a reading task, without assigning a formal quality judgment to a named trial.
Describe the difference before judging it
Read the category counts or the reported summary and spread. A starting difference may be small or large on its actual scale; its relevance needs context. Avoid translating a nonsignificant label into the groups were identical. Likewise, one visibly different starting characteristic is not by itself proof that the assignment procedure was manipulated.
For an invented example, two randomized groups have different proportions of participants working evening shifts. A summary claims that because the baseline test lacks a significance label, schedules were the same. A reader can preserve the observed proportions and ask how the trial addressed relevant starting information. The example supplies no trial result and does not recommend an adjustment model.
Keep allocation evidence on its own line
The methods should explain sequence generation and relevant assignment safeguards. Read that account directly. A table that looks balanced cannot establish that assignments were concealed; a table with chance differences cannot replace an investigation of the actual procedure. These are related parts of understanding the trial, with different evidence.
CONSORT’s explanation considers the magnitude of chance imbalances and the importance of measured characteristics more useful than baseline significance tests. That does not authorize a reader to choose covariates after seeing which analysis produces a preferred result. Preserve the planned analysis and any documented explanation of adjustments.
Build a starting-point note rather than a verdict
Your note can contain the described population, one starting difference that matters to the claim, its scale and the separate allocation account. Leave an unclear denominator or missing method unresolved. This output differs from a general p-value definition: it explains why a particular use of testing at baseline cannot supply the reassurance being requested.
Then move to the actual outcome definition, follow-up and effect estimate. A well-described baseline table does not substitute for them or promise the result applies to you. For health decisions, seek appropriate interpretation of the complete evidence. Your own starting record likewise need not match a research group to be useful for describing a practical situation and asking for support.
Sources and scope
Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.
Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write